The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.
The study inclusion criteria is patients with main trunk (VSM, SSV, AASV) reflux to be treated with EVLA, suffering C2-C3 varicose disease, age 18-years and no severe co-morbidities. Patients with written consent will be randomized to two primary treatments groups; EVLA only and EVLA combined with sclerotherapy of varicose tributaries. The primary outcome is the requirement additional sclerotherapy on 3 month control visit. Other study outcomes are pain, quality of life (veins questionnaire), severity score and also recurring of varicose disease at 1, 3 and 5 years.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
350
The aim is to combine the significance of for sclerotherapy at the primary EVLA treatment
Turku University Hospital
Turku, Finland
re-intervention
Requirement of re-intervention
Time frame: 3 months
Pain after procedure
Post procedural pain measured with VAS scale
Time frame: up to 3 months after the treatment
Quality of life before after procedure
Quality of life will be measured with Veins questionnaire
Time frame: up to 5 years
Recur
The recurring varicose veins
Time frame: up to 5 years
Surgical complications
Infections, DVT, Pulmonary embolus will be reported
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.